![]() |
市場調查報告書
商品編碼
1802940
全球腦機介面市場:2032 年預測-按產品、組件、技術、應用、最終用戶和地區進行分析Brain-Computer Interface Market Forecasts to 2032 - Global Analysis By Product (Invasive BCI, Partially Invasive BCI and Non-Invasive BCI), Component (Hardware, Software & Algorithms and Service), Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球腦機介面市場預計在 2025 年達到 31.3 億美元,到 2032 年將達到 107.9 億美元,預測期內的複合年成長率為 19.35%。
腦機介面 (BCI) 是最尖端科技消除了傳統的神經肌肉通路,實現了人腦與外部設備之間的直接通訊。透過讀取和分析來自感測器的神經訊號,BCI 可以將大腦活動轉化為操作電腦、輪椅、義肢甚至機器人系統的命令。由於 BCI 提供了恢復行動能力和溝通能力的新方法,這項技術在醫療行業中具有巨大潛力,特別是對於患有神經病變、癱瘓和言語障礙的人群。作為未來人機互動的主要力量,BCI 的應用研究不僅限於醫療領域,也擴展到遊戲、防禦和人機整合等領域。
據美國食品藥物管理局(FDA)稱,永久性臨床BCI植入的數量預計將在未來一年內增加一倍以上,但目前安裝的數量不到100個。
神經系統疾病增加和人口老化
推動 BCI 市場發展的主要因素之一是人口老化和帕金森氏症、阿茲海默症、癲癇和肌萎縮側索硬化症 (ALS) 等神經系統疾病的盛行率上升。限制行動和溝通的神經退化性疾病和運動障礙在老年人中很常見。 BCI 提供了一種恢復失去能力的創造性方法,讓患者可以使用思維主導的命令與周圍環境互動。人口老化也刺激了對輔助科技的長期需求,特別是在醫療保健系統高度發展的地區。此外,對高效復健和溝通工具的需求,再加上全球神經病變的持續增加,正在推動 BCI 的普及。
訊號複雜性和技術限制
腦波訊號高度複雜、動態變化且易受外界干擾,準確解碼這些訊號對腦機介面 (BCI) 構成了重大的技術挑戰。雖然侵入式技術精度高,但也存在顯著的健康風險;而腦電圖 (EEG) 等非侵入式技術通常信噪比較低,導致反應不準確或延遲。個體腦活動的差異進一步增加了校準的複雜性,並降低了系統的可靠性。此外,這些技術障礙阻礙了 BCI 解決方案的廣泛應用,限制了擴充性,並限制了其在臨床或受控研究環境之外的應用。
擴大醫療保健以外的用途
雖然腦機介面 (BCI) 在醫療產業的應用最為普遍,但其應用也有很多機會擴展到其他產業,包括遊戲、智慧家庭自動化、國防和教育。腦機介面可以創造思維控制的身臨其境型遊戲體驗,徹底改變互動娛樂。國防應用包括提高戰鬥中的情境察覺,並為士兵提供通訊工具。在課堂上,腦機介面可以用來支援殘疾學生、監控注意力並客製化教學內容。同時,與物聯網設備的整合可以實現透過腦波訊號直接控制家用電器。
與其他技術的競爭
腦機介面 (BCI) 市場也面臨其他最尖端科技的競爭,這些技術無需侵入式複雜操作即可提供類似的優勢。例如,人工智慧輔助設備、眼動追蹤系統、手勢控制以及先進的語音辨識工具已經提供了高效的通訊和行動解決方案。這些替代方案通常應用範圍更廣、更易於使用且價格更低,因此對患者和看護者更具吸引力。此外,除非腦機介面 (BCI) 能夠在成本效益、安全性和易用性方面展現出優於其他替代方案的明顯優勢,否則其應用可能會停滯不前。這種競爭壓力可能會限制市場佔有率,並阻礙長期成長前景。
新冠疫情以多種方式影響了腦機介面 (BCI) 市場,既帶來了挑戰,也帶來了機會。一方面,封鎖和限制措施擾亂了臨床試驗、推遲了產品開發、延緩了擇期神經外科手術,阻礙了侵入式 BCI 的普及。供應鏈中斷也影響了生產計劃和硬體供應。然而,疫情加速了數位醫療的普及,並凸顯了遠距神經病學、遠端監控以及為溝通和行動不便患者提供先進輔助技術的需求。穿戴式非侵入式 BCI 作為一種安全的居家心理健康、復健和遠端通訊解決方案,其受歡迎程度為該行業提供了持續的成長動力。
預計非侵入式 BCI 市場在預測期內將佔據最大佔有率
預計非侵入式腦機介面 (BCI) 領域將在預測期內佔據最大的市場佔有率。這主要是因為與侵入式或半侵入式系統相比,它們安全、價格低廉且易於使用。非侵入式腦機介面 (BCI) 正變得越來越適用於臨床和消費應用,因為它們使用腦電圖 (EEG) 和功能性近紅外線光譜 (fNIRS) 等技術來記錄腦波訊號,而無需手術植入。它們在遊戲、心理健康護理和智慧家庭控制等非醫療領域以及溝通輔助和復健等醫療領域也越來越受歡迎。
功能性近紅外線光譜 (fNIRS) 領域預計將在預測期內以最高複合年成長率成長
功能性近紅外線光譜 (fNIRS) 領域預計將在預測期內實現最高成長率,因為它作為一種可攜式、經濟實惠、非侵入式的神經成像方法的應用日益廣泛。 fNIRS 是一種比 fMRI 和 MEG 等笨重且昂貴的腦活動檢測法設備更安全、更實用的替代方案。 fNIRS 的便攜性、易用性和對實際應用的適用性使其在復健、認知訓練、心理健康監測和人機互動方面極具吸引力。此外,隨著消費者、醫療保健和教育領域對穿戴式且方便用戶使用的腦機介面 (BCI) 的需求日益成長,fNIRS 正迅速成為首選技術。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其在神經技術研究方面的大量投資、先進的醫療基礎設施以及強大的技術生態系統。眾多領先企業、新興企業和學術機構積極開發用於臨床和消費者的侵入式和非侵入式腦機介面 (BCI),是推動這一成長的關鍵因素。政府資助、監管支持以及神經病變患者對輔助技術日益成長的需求,進一步加速了輔助技術的採用。此外,該地區的高認知度、尖端醫療設備的快速普及以及學術機構、醫療機構和高科技公司之間的合作,進一步增強了該地區的優勢,使北美成為腦機介面商業化的全球領導者。
預計亞太地區將在預測期內呈現最高的複合年成長率,這得益於神經系統疾病的增多、醫療基礎設施的快速發展以及中國、日本、韓國和印度等國家對神經技術研究投入的不斷增加。地方政府和私人公司正在積極資助腦機介面(BCI)的開發,以促進自主創新生態系統,並減少對西方技術的依賴。智慧家庭、遊戲和教育應用對穿戴式和非侵入式腦機介面(BCI)的需求日益成長,也進一步刺激了其應用。此外,由於人口眾多、中階醫療保健支出不斷成長以及數位轉型的強勁勢頭,亞太地區有望成為成長最快的市場。
According to Stratistics MRC, the Global Brain-Computer Interface Market is accounted for $3.13 billion in 2025 and is expected to reach $10.79 billion by 2032 growing at a CAGR of 19.35% during the forecast period. A brain-computer interface, or BCI, is a cutting-edge technology that eliminates the need for conventional neuromuscular pathways and permits direct communication between the human brain and external devices. BCIs can convert brain activity into commands that operate computers, wheelchairs, prosthetic limbs, and even robotic systems by reading and analyzing neural signals from sensors. Because it provides new means of regaining mobility and communication, this technology has enormous potential in the healthcare industry, especially for those with neurological disorders, paralysis, or speech impairments. As a major force behind future human-technology interaction, BCIs are being investigated for use in gaming, defense, and human-machine integration in addition to medical applications.
According to the U.S. Food and Drug Administration (FDA), the number of permanent clinical BCI implants is expected to more than double within the next year, although fewer than 100 such devices are currently installed.
Growing neurological disorder prevalence and aging populations
One of the main factors propelling the BCI market is the rising prevalence of neurological conditions like Parkinson's disease, Alzheimer's, epilepsy, and amyotrophic lateral sclerosis (ALS), as well as the aging population. Neurodegenerative diseases and motor impairments that limit mobility and communication are more common in older adults. BCIs offer creative ways to regain lost abilities, allowing patients to use thought-driven commands to interact with their surroundings. Long-term demand for assistive technologies is also fueled by the aging population, especially in areas with highly developed healthcare systems. Moreover, the need for efficient rehabilitation and communication tools, coupled with the ongoing global increase in neurological disorders, is driving the adoption of BCI.
Signal complexity and technical restrictions
Accurately decoding brain signals-which are extremely complex, dynamic, and prone to outside interference-presents substantial technical challenges for BCIs. While invasive techniques offer higher accuracy but come with greater health risks, non-invasive techniques, such as EEG, frequently produce low signal-to-noise ratios, which can result in inaccurate or delayed responses. Individual differences in brain activity make calibration even more difficult, which reduces the systems' dependability for widespread use. Furthermore, broad adoption of BCI solutions is being slowed down by these technical obstacles, which also restrict their scalability and prevent them from being used outside of clinical or controlled research settings.
Extending uses outside of healthcare
The adoption of BCI is still most prevalent in the healthcare industry, but there are also a lot of opportunities to expand applications to other industries like gaming, smart home automation, defense, and education. BCIs can create thought-controlled, immersive gaming experiences that revolutionize interactive entertainment. Applications for defense include improved situational awareness during combat and communication tools for soldiers. BCIs can be used in the classroom to support students with disabilities, monitor attention spans, and customize instruction. Integration with IoT devices, meanwhile, may enable direct brain signal control of household appliances.
Competition from other technologies
The market for BCI is also at risk from competition from other cutting-edge technologies that can provide comparable advantages without requiring invasive or difficult procedures. AI-powered assistive devices, eye-tracking systems, gesture-based controls, and sophisticated voice recognition tools, for example, already offer efficient communication and mobility solutions. These substitutes are more appealing to patients and caregivers because they are frequently more widely accessible, user-friendly, and less expensive. Moreover, the adoption of BCIs may stall if they are unable to show a definite advantage over alternatives in terms of cost-effectiveness, safety, and usability. This pressure from competitors may restrict market share and impede long-term growth prospects.
The COVID-19 pandemic had a mixed impact on the Brain-Computer Interface (BCI) market, creating both challenges and opportunities. On the one hand, lockdowns and restrictions hindered the adoption of invasive BCIs by interfering with clinical trials, delaying product development, and slowing elective neurosurgical procedures. Manufacturing schedules and hardware availability were also affected by supply chain disruptions. However, the pandemic hastened the adoption of digital health and brought attention to the necessity of tele-neurology, remote monitoring, and sophisticated assistive technologies for patients with communication or mobility impairments. Wearable and non-invasive BCIs attracted interest as secure, at-home options for mental health, rehabilitation, and remote communication, generating sustained growth momentum for the industry.
The non-invasive BCI segment is expected to be the largest during the forecast period
The non-invasive BCI segment is expected to account for the largest market share during the forecast period, mainly because, in contrast to invasive and partially invasive systems, it is safe, inexpensive, and simple to use. Non-invasive brain-computer interfaces (BCIs) are more accessible for clinical and consumer applications because they use technologies such as electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) to record brain signals without the need for surgical implantation. They are becoming more and more popular in non-medical fields like gaming, mental wellness, and smart home control, as well as in healthcare for communication support and rehabilitation.
The functional near-infrared spectroscopy (fNIRS) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the functional near-infrared spectroscopy (fNIRS) segment is predicted to witness the highest growth rate because of its increasing use as a portable, affordable, and non-invasive neuroimaging method. Blood oxygenation changes are tracked by fNIRS, a safer and more practical alternative to large, expensive modalities like fMRI or MEG for measuring brain activity. It is very appealing for rehabilitation, cognitive training, mental health monitoring, and human-computer interaction because of its portability, simplicity of use, and suitability for real-world applications. Additionally, fNIRS is quickly becoming a preferred technology as the need for wearable and user-friendly BCIs increases in the consumer, healthcare, and educational sectors.
During the forecast period, the North America region is expected to hold the largest market share, driven by its substantial investments in neurotechnology research, sophisticated healthcare infrastructure, and robust technological ecosystem. Leading businesses, start-ups, and academic institutions actively creating invasive and non-invasive BCIs for clinical and consumer use are present in the area, which is advantageous. Adoption is further accelerated by favorable government funding, regulatory support, and growing patient demand for assistive technologies among those with neurological disorders. Furthermore, the region's dominance is reinforced by high awareness, quick adoption of cutting-edge medical devices, and partnerships between academic institutions, healthcare facilities, and tech companies, making North America the world leader in BCI commercialization.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by the rise in neurological disorders in nations like China, Japan, South Korea, and India, the quick development of healthcare infrastructure; and growing investments in neurotechnology research. The development of BCI is being actively funded by regional governments and private companies in an effort to boost indigenous innovation ecosystems and lessen reliance on Western technologies. Adoption is further accelerated by the growing need for wearable, non-invasive BCIs in smart home, gaming, and educational applications. Moreover, Asia-Pacific is becoming the fastest-growing market due to its large population, rising middle-class healthcare spending, and robust digital transformation.
Key players in the market
Some of the key players in Brain-Computer Interface Market include Cadwell Industries, G.Tec Medical Enginneering Gmbh, Emotiv Systems Inc., Advanced Brain Monitoring, Inc., Natus Medical Incorporated, Compumedics, Ltd, Blackrock Neurotech Inc, Medtronic, Paradromics, Bitbrain Technologies, Nihon Kohden Corporation, Synchron, NeuroSky Inc, BrainCo, Inc., Mind Technologies, Inc and Kernel Inc.
In July 2025, Compumedics Limited announced the signing of two new 4-year distribution agreements with long-standing partners in China. The agreements, valued at A$24.4 million in total, further strengthen Compumedics' presence across key regions in Asia. The first, a A$20 million agreement, extends the Company's established partnership with its long-term Northern China distributor focused on sleep diagnostics.
In April 2025, Medtronic announced that it has entered into an agreement with Retia Medical, an innovative digital health company that develops advanced hemodynamic solutions, to distribute the Argos(TM) cardiac output monitor. The Argos(TM) monitor provides healthcare professionals with accurate hemodynamic data to support the treatment of high-risk surgical and critically ill patients.
In April 2025, Cadwell Industries has launched its latest Sierra software release providing patent-pending, synchronized ultrasound and electromyography (EMG). Combined with the Sierra Summit electrodiagnostic system and Sierra NMUS1 integrated ultrasound, the update brings electrophysiological data and ultrasound imaging together in real-time on a single screen.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.